Back
MiNK Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
30
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.69
Seasonality Move:
-20.14%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiMiNK Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, MiNK Therapeutics, Inc. has on average historically fallen by 28.8% based on the past 4 years of stock performance.
-
MiNK Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is MiNK Therapeutics, Inc. Stock Undervalued?The current MiNK Therapeutics, Inc. [INKT] share price is $11.50. The Score for INKT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will MiNK Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, MiNK Therapeutics, Inc. has on average historically fallen by 28.8% based on the past 4 years of stock performance.
MiNK Therapeutics, Inc. Stock Rating
Sell
30
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. overpriced?
-
MiNK Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
MiNK Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
minktherapeutics.com
52-Week Data
52-Week High:
76.00
52-Week Low:
4.56
Prediction Charts
Market Cap:
54M
Price in USD:
11.50
Volume:
20K
Beta:
0.34
Technical Analysis
SMA50:
13.28
SMA100:
14.41
SMA200:
11.74
52-Wk Change:
68.47%
Stock Predictions
-
Is MiNK Therapeutics, Inc. stock public?Yes, MiNK Therapeutics, Inc. is a publicly traded company.
-
What is the MiNK Therapeutics, Inc. stock quote today?The MiNK Therapeutics, Inc. stock price is 11.50 USD today.
-
How to buy MiNK Therapeutics, Inc. stock online?You can buy MiNK Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 12.90 | 12.00 | 12.90 | 12.00 |
| Nov-18 | 11.81 | 11.31 | 11.87 | 10.79 |
| Nov-19 | 11.48 | 11.02 | 11.59 | 10.75 |
| Nov-20 | 11.00 | 10.88 | 11.99 | 10.69 |
| Nov-21 | 10.61 | 10.56 | 11.30 | 10.51 |
| Nov-24 | 10.58 | 11.02 | 11.19 | 10.58 |
| Nov-25 | 10.71 | 10.91 | 11.26 | 10.54 |
| Nov-26 | 10.99 | 11.16 | 11.52 | 10.99 |
| Nov-28 | 11.39 | 10.51 | 11.39 | 10.51 |
| Dec-1 | 10.73 | 11.09 | 11.60 | 10.60 |
| Dec-2 | 10.77 | 10.72 | 11.10 | 10.72 |
| Dec-3 | 10.72 | 10.93 | 11.06 | 10.72 |
| Dec-4 | 10.92 | 12.35 | 12.50 | 10.51 |
| Dec-5 | 12.27 | 11.50 | 12.38 | 11.50 |
MiNK Therapeutics, Inc. Earnings
MiNK Therapeutics, Inc. Earnings Report: Per Share MiNK Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
MiNK Therapeutics, Inc. Forecast Revenue Growth
MiNK Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for MiNK Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
* MiNK Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.